Literature DB >> 15956261

Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine-resistant cancer cells.

Kurtis E Bachman1, Jason Sager, Ian Cheong, Marco Catto, Alberto Bardelli, Ben Ho Park, Bert Vogelstein, Angelo Carotti, Kenneth W Kinzler, Christoph Lengauer.   

Abstract

The dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) is a heterocyclic amine and is a common byproduct of cooked meat and fish. Although most cells undergo apoptosis when exposed to this mutagen, subsets develop resistance. Rather than die, these resistant cells persist and accumulate mutations, thereby driving tumorigenesis of exposed organs within the gastrointestinal tract. By applying a high-throughput cell-based screen of 32,000 small molecules, we have identified a family of compounds that specifically inhibit the growth of PhIP-resistant cancer cells. These compounds may prove useful for the treatment or prevention of gastrointestinal tumors arising after exposure to PhIP and related carcinogens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956261     DOI: 10.1158/1535-7163.MCT-05-0038

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  5 in total

1.  Small Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein Conformations.

Authors:  Michael C Cavalier; Mohd Imran Ansari; Adam D Pierce; Paul T Wilder; Laura E McKnight; E Prabhu Raman; David B Neau; Padmavani Bezawada; Milad J Alasady; Thomas H Charpentier; Kristen M Varney; Eric A Toth; Alexander D MacKerell; Andrew Coop; David J Weber
Journal:  J Med Chem       Date:  2016-01-13       Impact factor: 7.446

2.  Novel protein-inhibitor interactions in site 3 of Ca(2+)-bound S100B as discovered by X-ray crystallography.

Authors:  Michael C Cavalier; Zephan Melville; Ehson Aligholizadeh; E Prabhu Raman; Wenbo Yu; Lei Fang; Milad Alasady; Adam D Pierce; Paul T Wilder; Alexander D MacKerell; David J Weber
Journal:  Acta Crystallogr D Struct Biol       Date:  2016-05-25       Impact factor: 7.652

3.  A novel small molecule that selectively inhibits glioblastoma cells expressing EGFRvIII.

Authors:  Dimitri G Trembath; Anita Lal; David J Kroll; Nicholas H Oberlies; Gregory J Riggins
Journal:  Mol Cancer       Date:  2007-04-16       Impact factor: 27.401

4.  Covalent small molecule inhibitors of Ca(2+)-bound S100B.

Authors:  Michael C Cavalier; Adam D Pierce; Paul T Wilder; Milad J Alasady; Kira G Hartman; David B Neau; Timothy L Foley; Ajit Jadhav; David J Maloney; Anton Simeonov; Eric A Toth; David J Weber
Journal:  Biochemistry       Date:  2014-10-14       Impact factor: 3.162

5.  Genetic targeting of B-RafV600E affects survival and proliferation and identifies selective agents against BRAF-mutant colorectal cancer cells.

Authors:  Benjamin Hirschi; Eike Gallmeier; Andreas Ziesch; Maximilian Marschall; Frank T Kolligs
Journal:  Mol Cancer       Date:  2014-05-24       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.